Cargando…
Development of a perfusion process for serum-free adenovirus vector herpes zoster vaccine production
Herpes zoster is caused by reactivation of the varicella zoster virus (VZV). Researching and developing a herpes zoster vaccine will help to decrease the incidence of herpes zoster. To increase the bioreactor productivity, a serum-free HEK293 cell perfusion process with adenovirus vector herpes zost...
Autores principales: | Sun, Yang, Huang, Lingling, Nie, Jianqi, Feng, Kai, Liu, Yupeng, Bai, Zhonghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107214/ https://www.ncbi.nlm.nih.gov/pubmed/35567723 http://dx.doi.org/10.1186/s13568-022-01398-7 |
Ejemplares similares
-
Optimization of an adenovirus-vectored zoster vaccine production process with chemically defined medium and a perfusion system
por: Nie, Jianqi, et al.
Publicado: (2022) -
The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process
por: Nie, Jianqi, et al.
Publicado: (2022) -
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023) -
Herpes Zoster Vaccination
por: Kim, Kyung Hoon
Publicado: (2013) -
Herpes Zoster Vaccines
por: Harbecke, Ruth, et al.
Publicado: (2021)